JP2005500986A5 - - Google Patents

Download PDF

Info

Publication number
JP2005500986A5
JP2005500986A5 JP2002573767A JP2002573767A JP2005500986A5 JP 2005500986 A5 JP2005500986 A5 JP 2005500986A5 JP 2002573767 A JP2002573767 A JP 2002573767A JP 2002573767 A JP2002573767 A JP 2002573767A JP 2005500986 A5 JP2005500986 A5 JP 2005500986A5
Authority
JP
Japan
Prior art keywords
ethyl
benzofuran
methyl
pyrrolidinyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002573767A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005500986A (ja
JP4612990B2 (ja
Filing date
Publication date
Priority claimed from US09/810,648 external-priority patent/US20020177589A1/en
Priority claimed from US10/044,495 external-priority patent/US20020183309A1/en
Priority claimed from US10/081,207 external-priority patent/US6969730B2/en
Application filed filed Critical
Priority claimed from PCT/US2002/007107 external-priority patent/WO2002074758A2/en
Publication of JP2005500986A publication Critical patent/JP2005500986A/ja
Publication of JP2005500986A5 publication Critical patent/JP2005500986A5/ja
Application granted granted Critical
Publication of JP4612990B2 publication Critical patent/JP4612990B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002573767A 2001-03-16 2002-03-11 ヒスタミン−3受容体リガンドとしての新規アミンおよびそれらの治療的適用 Expired - Fee Related JP4612990B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/810,648 US20020177589A1 (en) 2001-03-16 2001-03-16 Novel amines as histamine-3 receptor ligands and their therapeutic applications
US10/044,495 US20020183309A1 (en) 2001-03-16 2002-01-11 Novel amines as histamine-3 receptor ligands and their therapeutic applications
US10/081,207 US6969730B2 (en) 2001-03-16 2002-02-25 Amines as histamine-3 receptor ligands and their therapeutic applications
PCT/US2002/007107 WO2002074758A2 (en) 2001-03-16 2002-03-11 Novel amines as histamine-3 receptor ligands and their therapeutic applications

Publications (3)

Publication Number Publication Date
JP2005500986A JP2005500986A (ja) 2005-01-13
JP2005500986A5 true JP2005500986A5 (US06653308-20031125-C00057.png) 2005-12-22
JP4612990B2 JP4612990B2 (ja) 2011-01-12

Family

ID=27366495

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002573767A Expired - Fee Related JP4612990B2 (ja) 2001-03-16 2002-03-11 ヒスタミン−3受容体リガンドとしての新規アミンおよびそれらの治療的適用

Country Status (7)

Country Link
EP (2) EP1370546A2 (US06653308-20031125-C00057.png)
JP (1) JP4612990B2 (US06653308-20031125-C00057.png)
AR (1) AR035783A1 (US06653308-20031125-C00057.png)
BR (1) BR0205829A (US06653308-20031125-C00057.png)
CA (1) CA2440238C (US06653308-20031125-C00057.png)
MX (1) MXPA03008319A (US06653308-20031125-C00057.png)
WO (1) WO2002074758A2 (US06653308-20031125-C00057.png)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7314937B2 (en) 2002-03-21 2008-01-01 Eli Lilly And Company Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses
US6822101B2 (en) 2002-09-16 2004-11-23 Abbott Laboratories Process for preparing amine-substituted benzofurans
US7153889B2 (en) 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
PL376751A1 (pl) * 2002-11-12 2006-01-09 Abbott Laboratories Bicykliczne podstawione aminy jako ligandy receptora histaminowego-3
US7244852B2 (en) 2003-02-27 2007-07-17 Abbott Laboratories Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
CN101928284A (zh) 2003-03-14 2010-12-29 小野药品工业株式会社 含氮杂环衍生物以及包含所述化合物作为活性成分的药物
CA2521000A1 (en) * 2003-04-03 2004-10-21 Kyowa Hakko Kogyo Co., Ltd. Preventive and/or therapeutic agent for neuropathic pain
US7094790B2 (en) 2003-05-07 2006-08-22 Abbott Laboratories Fused bicyclic-substituted amines as histamine-3 receptor ligands
US20040224952A1 (en) * 2003-05-07 2004-11-11 Cowart Marlon D. Fused bicyclic-substituted amines as histamine-3 receptor ligands
CA2524787A1 (en) * 2003-05-07 2004-11-25 Abbott Laboratories Fused bicyclic-substituted amines as histamine-3 receptor ligands
CA2542220A1 (en) * 2003-10-22 2005-05-06 Eli Lilly And Company Novel mch receptor antagonists
SE0303480D0 (sv) * 2003-12-19 2003-12-19 Biovitrum Ab Benzofuranes
AU2005219791B2 (en) * 2004-03-05 2011-06-09 Msd K.K. Diaryl-substituted five-membered heterocycle derivative
WO2005097127A2 (en) 2004-04-02 2005-10-20 Merck & Co., Inc. Method of treating men with metabolic and anthropometric disorders
US7098222B2 (en) 2004-05-12 2006-08-29 Abbott Laboratories Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
US7205316B2 (en) 2004-05-12 2007-04-17 Abbott Laboratories Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
US20050256309A1 (en) * 2004-05-12 2005-11-17 Altenbach Robert J Tri-and bi-cyclic heteroaryl histamine-3 receptor ligands
US7145005B2 (en) 2004-05-12 2006-12-05 Abbott Laboratories 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
US20050256118A1 (en) * 2004-05-12 2005-11-17 Altenbach Robert J Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
DE102004030099A1 (de) * 2004-06-22 2006-01-12 Grünenthal GmbH Gesättigte und ungesättigte 3-Pyridyl-benzocycloalkylmethyl-amine als Serotonin- und/oder Noradrenalin-Reuptake-Hemmer und/oder µ-Opioidrezeptor-Modulatoren
US8143404B2 (en) * 2004-09-13 2012-03-27 Ono Pharmaceutical Co., Ltd Nitrogenous heterocylic derivative and medicine containing the same as an active ingredient
CA2610655A1 (en) 2005-06-03 2006-12-14 Abbott Laboratories Cyclobutyl amine derivatives
US8003642B2 (en) 2006-03-10 2011-08-23 Ono Pharmaceutical Co., Ltd. Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
WO2007149395A2 (en) * 2006-06-20 2007-12-27 Amphora Discovery Corporation 2,5-substituted oxazole derivatives as protein kinase inhibitors for the treatment of cancer
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
CN103382174A (zh) 2006-06-23 2013-11-06 雅培制药有限公司 作为组胺h3受体调节物的环丙胺衍生物
EP2221298B1 (en) 2007-11-13 2013-11-06 Taisho Pharmaceutical Co., Ltd Phenylpyrazole derivatives
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
EP2344484B1 (en) * 2008-10-17 2016-06-08 Akaal Pharma Pty Ltd S1p receptors modulators and use thereof
EP2344446A4 (en) 2008-10-17 2012-04-04 Akaal Pharma Pty Ltd S1P RECEPTOR MODULATORS
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
JP2012082186A (ja) * 2010-09-15 2012-04-26 Bayer Cropscience Ag 殺虫性アリールピロリジン類
GB201113538D0 (en) * 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
EP3309150B1 (en) * 2013-01-09 2021-06-02 Arena Pharmaceuticals, Inc. (r)-3-(4'-(2-(2-methylpyrrolidin-1-yl)ethyl)biphenyl-4-yl)propanoic acid as histamine h3 receptor modulators for the treatment of cognitive disorders
EP3236964A4 (en) * 2014-12-22 2018-09-19 Teva Pharmaceuticals International GmbH L-tartrate salt of pridopidine
CN109456292B (zh) * 2018-10-23 2022-06-10 中山大学 一种海洋真菌来源的香豆素类化合物及其制备方法与应用
EP4251148A1 (en) 2020-11-27 2023-10-04 Richter Gedeon Nyrt. Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder
CN114805261B (zh) * 2021-01-18 2023-03-21 沈阳药科大学 苯并呋喃类lsd1抑制剂及其制备方法
CN115385885A (zh) * 2022-05-05 2022-11-25 深圳海创生物科技有限公司 一种蓝莓多酚、组合物及其在制备具有降血脂和/或减肥作用的药物或食品中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237144A (en) * 1979-06-21 1980-12-02 Merck & Co., Inc. 2,3-Dihydro-2,6,7-trisubstituted-5-acylbenzofurans
IL101785A0 (en) * 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5436246A (en) * 1992-09-17 1995-07-25 Merrell Dow Pharmaceuticals Inc. Serotonin receptor agents
JP2759257B2 (ja) * 1993-09-28 1998-05-28 大塚製薬株式会社 糖尿病治療剤
JPH07173158A (ja) * 1993-12-17 1995-07-11 Taiho Yakuhin Kogyo Kk チアゾリジンジオン誘導体又はその塩
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
US6130187A (en) * 1996-02-09 2000-10-10 Kumiai Chemical Industry Co., Ltd. Benzofuran-7-yl uracil derivatives and herbicides
US6077812A (en) * 1997-02-26 2000-06-20 Fmc Corporation Cycloimido-substituted benzofused heterocyclic herbicides
WO1998052946A1 (en) * 1997-12-02 1998-11-26 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
EP0982300A3 (en) * 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
EP0978512A1 (en) * 1998-07-29 2000-02-09 Societe Civile Bioprojet Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications
WO2002010156A1 (en) * 2000-07-29 2002-02-07 Arpida Ag Benzofuran derivatives and their use as antibacterial agents

Similar Documents

Publication Publication Date Title
JP2005500986A5 (US06653308-20031125-C00057.png)
CA2440238A1 (en) Novel amines as histamine-3 receptor ligands and their therapeutic applications
AU2006328602B2 (en) Aryl-isoxazolo-4-yl-oxadiazole derivatives
JP2007508346A5 (US06653308-20031125-C00057.png)
JP2019077725A5 (US06653308-20031125-C00057.png)
JP2007510713A5 (US06653308-20031125-C00057.png)
CA2396824A1 (en) Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
RU2417226C2 (ru) Производные азаиндол-2-карбоксамида
JP2006500348A5 (US06653308-20031125-C00057.png)
JP2014511869A5 (US06653308-20031125-C00057.png)
JP2012520238A5 (US06653308-20031125-C00057.png)
JP2018520201A5 (US06653308-20031125-C00057.png)
JP2003525872A5 (US06653308-20031125-C00057.png)
JP2015533157A5 (US06653308-20031125-C00057.png)
JP2017524026A5 (US06653308-20031125-C00057.png)
HRP20160421T1 (hr) Derivat azola
JP2006503081A5 (US06653308-20031125-C00057.png)
CA2575003A1 (en) Potassium channel inhibitors
RU2017124425A (ru) Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg
RU2012116207A (ru) Производные индола в качестве модуляторов crac
RU2010137300A (ru) Модуляторы бета-амилоида
JP2003507328A5 (US06653308-20031125-C00057.png)
RU2010130175A (ru) Производные бензотиазола и бензоксазола и способы их применения
JP2018507235A5 (US06653308-20031125-C00057.png)
KR20120054106A (ko) 칸나비노이드 수용체 1 활성의 억제제로서 화합물 및 조성물